Arcticzymes Technologies ASA
OSE:AZT

Watchlist Manager
Arcticzymes Technologies ASA Logo
Arcticzymes Technologies ASA
OSE:AZT
Watchlist
Price: 16.75 NOK 1.82% Market Closed
Market Cap: 855.4m NOK

EV/EBIT
Enterprise Value to EBIT

-472.6
Current
69.2
Median
3.8
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-472.6
=
Enterprise Value
680.5m NOK
/
EBIT
-1.4m NOK
EBIT Growth EV/EBIT to Growth
NO
Arcticzymes Technologies ASA
OSE:AZT
Average EV/EBIT: 20.1
Negative Multiple: -472.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -200 467.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.2
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
22.4
31%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.7
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.9
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -542.3 N/A N/A
AU
CSL Ltd
ASX:CSL
21.3
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14.9
13%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -57.5 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -315.5 N/A N/A

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
224.6
2-Years Forward
EV/EBIT
42.1
3-Years Forward
EV/EBIT
22.1